Crinetics Pharmaceuticals CRNX Interest Income
Interest Income at other companies
Other financials
Where this comes from
Reported directly by Crinetics Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.
The official record: Crinetics Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Crinetics Pharmaceuticals's interest income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Crinetics Pharmaceuticals's interest income?
- Crinetics Pharmaceuticals (CRNX) reported interest income of $12.66M in Q1 2026.
- How has Crinetics Pharmaceuticals's interest income changed year-over-year?
- Crinetics Pharmaceuticals's interest income decreased by 14.6% year-over-year, from $14.83M to $12.66M.
- What is the long-term trend for Crinetics Pharmaceuticals's interest income?
- Over 4 years (2021 to 2025), Crinetics Pharmaceuticals's interest income has grown at a 326.6% compound annual growth rate (CAGR), from $157K to $51.99M.
- What does interest income mean?
- Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.